Logo image of S

SENTINELONE INC -CLASS A (S) Stock Fundamental Analysis

NYSE:S - New York Stock Exchange, Inc. - US81730H1095 - Common Stock - Currency: USD

16.17  -0.65 (-3.86%)

After market: 16.229 +0.06 (+0.36%)

Fundamental Rating

4

Taking everything into account, S scores 4 out of 10 in our fundamental rating. S was compared to 285 industry peers in the Software industry. S scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. S shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year S was profitable.
In the past year S had a positive cash flow from operations.
In the past 5 years S always reported negative net income.
S had negative operating cash flow in 4 of the past 5 years.
S Yearly Net Income VS EBIT VS OCF VS FCFS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B -5B 10B -10B

1.2 Ratios

S's Return On Assets of -11.99% is on the low side compared to the rest of the industry. S is outperformed by 62.81% of its industry peers.
S has a Return On Equity of -17.28%. This is comparable to the rest of the industry: S outperforms 44.91% of its industry peers.
Industry RankSector Rank
ROA -11.99%
ROE -17.28%
ROIC N/A
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
S Yearly ROA, ROE, ROICS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1.3 Margins

With a decent Gross Margin value of 74.30%, S is doing good in the industry, outperforming 66.32% of the companies in the same industry.
S's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for S so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
S Yearly Profit, Operating, Gross MarginsS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

S does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for S has been increased compared to 1 year ago.
The number of shares outstanding for S has been increased compared to 5 years ago.
S has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
S Yearly Shares OutstandingS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
S Yearly Total Debt VS Total AssetsS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B

2.2 Solvency

An Altman-Z score of 3.68 indicates that S is not in any danger for bankruptcy at the moment.
S has a better Altman-Z score (3.68) than 65.61% of its industry peers.
S has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.68
ROIC/WACCN/A
WACC10.98%
S Yearly LT Debt VS Equity VS FCFS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B 20B 30B

2.3 Liquidity

S has a Current Ratio of 1.74. This is a normal value and indicates that S is financially healthy and should not expect problems in meeting its short term obligations.
S's Current ratio of 1.74 is in line compared to the rest of the industry. S outperforms 53.33% of its industry peers.
S has a Quick Ratio of 1.74. This is a normal value and indicates that S is financially healthy and should not expect problems in meeting its short term obligations.
S has a Quick ratio of 1.74. This is comparable to the rest of the industry: S outperforms 53.68% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74
S Yearly Current Assets VS Current LiabilitesS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 117.86% over the past year.
S shows a strong growth in Revenue. In the last year, the Revenue has grown by 32.25%.
S shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 77.59% yearly.
EPS 1Y (TTM)117.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)32.25%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%29.48%

3.2 Future

Based on estimates for the next years, S will show a very strong growth in Earnings Per Share. The EPS will grow by 86.30% on average per year.
S is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.53% yearly.
EPS Next Y282.54%
EPS Next 2Y165.86%
EPS Next 3Y117.83%
EPS Next 5Y86.3%
Revenue Next Year23.74%
Revenue Next 2Y22.9%
Revenue Next 3Y21.84%
Revenue Next 5Y22.53%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
S Yearly Revenue VS EstimatesS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
S Yearly EPS VS EstimatesS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 323.40, the valuation of S can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as S.
The average S&P500 Price/Earnings ratio is at 27.63. S is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 84.54, which means the current valuation is very expensive for S.
The rest of the industry has a similar Price/Forward Earnings ratio as S.
When comparing the Price/Forward Earnings ratio of S to the average of the S&P500 Index (20.85), we can say S is valued expensively.
Industry RankSector Rank
PE 323.4
Fwd PE 84.54
S Price Earnings VS Forward Price EarningsS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

S's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 808.65
EV/EBITDA N/A
S Per share dataS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
S's earnings are expected to grow with 117.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.14
PEG (5Y)N/A
EPS Next 2Y165.86%
EPS Next 3Y117.83%

More info and screens

0

5. Dividend

5.1 Amount

S does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SENTINELONE INC -CLASS A

NYSE:S (4/21/2025, 8:04:01 PM)

After market: 16.229 +0.06 (+0.36%)

16.17

-0.65 (-3.86%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-12 2025-03-12/amc
Earnings (Next)05-28 2025-05-28/amc
Inst Owners86.49%
Inst Owner Change0.48%
Ins Owners0.46%
Ins Owner Change4.55%
Market Cap5.33B
Analysts80.95
Price Target25.06 (54.98%)
Short Float %4.83%
Short Ratio2.78
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.41%
Min EPS beat(2)-100%
Max EPS beat(2)174.81%
EPS beat(4)3
Avg EPS beat(4)126.1%
Min EPS beat(4)-100%
Max EPS beat(4)329.6%
EPS beat(8)7
Avg EPS beat(8)84.66%
EPS beat(12)11
Avg EPS beat(12)63.29%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.52%
Max Revenue beat(2)-0.52%
Revenue beat(4)1
Avg Revenue beat(4)-0.59%
Min Revenue beat(4)-1.52%
Max Revenue beat(4)0.89%
Revenue beat(8)4
Avg Revenue beat(8)0.13%
Revenue beat(12)7
Avg Revenue beat(12)0.83%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.25%
PT rev (3m)-18.08%
EPS NQ rev (1m)-15.34%
EPS NQ rev (3m)-48.8%
EPS NY rev (1m)-4.86%
EPS NY rev (3m)-3.62%
Revenue NQ rev (1m)-0.35%
Revenue NQ rev (3m)-2.62%
Revenue NY rev (1m)-1.62%
Revenue NY rev (3m)-1.53%
Valuation
Industry RankSector Rank
PE 323.4
Fwd PE 84.54
P/S 6.49
P/FCF 808.65
P/OCF 158.05
P/B 3.19
P/tB 5.72
EV/EBITDA N/A
EPS(TTM)0.05
EY0.31%
EPS(NY)0.19
Fwd EY1.18%
FCF(TTM)0.02
FCFY0.12%
OCF(TTM)0.1
OCFY0.63%
SpS2.49
BVpS5.06
TBVpS2.83
PEG (NY)1.14
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.99%
ROE -17.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.3%
FCFM 0.8%
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
F-Score6
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 63.45%
Cap/Sales 3.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z 3.68
F-Score6
WACC10.98%
ROIC/WACCN/A
Cap/Depr(3y)58.32%
Cap/Depr(5y)105.17%
Cap/Sales(3y)3.59%
Cap/Sales(5y)4.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y282.54%
EPS Next 2Y165.86%
EPS Next 3Y117.83%
EPS Next 5Y86.3%
Revenue 1Y (TTM)32.25%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%29.48%
Revenue Next Year23.74%
Revenue Next 2Y22.9%
Revenue Next 3Y21.84%
Revenue Next 5Y22.53%
EBIT growth 1Y11.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year308.14%
EBIT Next 3Y95.42%
EBIT Next 5Y62.03%
FCF growth 1Y107.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.33%
OCF growth 3YN/A
OCF growth 5YN/A